1YTop 25% of the group
Rank 9 of 63 funds
Return +23.48%
1Y returns of 63 funds in the Health Care group, sorted from highest to lowest. This fund ranks 9No. 1 is SCBGENOME(E) +62.13%
Krungsri Global Healthcare Equity Fund
Shows where this fund stands in its group. Not investment advice · Data as of 3 Nov 2026
KFHEALTH-A invests through the master fund JPMorgan Funds - Global Healthcare Fund 99.06%
This fundKFHEALTH-A
The fund that actually investsJPMorgan Funds - Global Healthcare FundThis fund and the master fund each charge their own fees. See the fees section of this page for the actual fees
Eli Lilly and Co LLY7.92%
ABBVIE ABBV7.23%Data as of 30 Sep 2026 · Top 6 shown, the rest grouped as Other · per JPMorgan fact sheet
Over the past year it was in the top 25% of its group; over 5 years it returned +2.74% per year (Top 25% of the group)
No. 1 is SCBGENOME(E) +62.13%
Each bar is one fund in the AIMC Health Care group, sorted from highest to lowest return · Every share class is counted, and only funds with a full track record for the period are included · Calculated from NAV as of 3 Nov 2026
Past performance is not a guarantee of future results
| YTD | 1W | 2W | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | MAX |
|---|---|---|---|---|---|---|---|---|---|---|
| +18.60% | +3.10% | +4.53% | +11.03% | +10.00% | +21.52% | +23.48% | +27.40% | +14.47% | +84.38% | +82.58% |
Total return over each period, matching the NAV chart periods · Not annualised
Largest drawdown in the selected period −24.91% Previous peak 25 Jul 2024 (NAV 14.3832) → Trough 7 Aug 2025 (NAV 10.8003) · Back to the previous peak on 19 Aug 2026, after 1 year
Currently −0.11% from the peak NAV of 14.9641 (30 Oct 2026)
Over 5 years, KFHEALTH-A returned 0.17 per unit of volatility, ranking 7 of 33 funds · The highest is FP HCARE-A (0.43)
กองทุนจะลงทุนในหน่วยลงทุนของกองทุนรวมต่างประเทศที่มีเป้าหมายให้ผลตอบแทนในการถือครองหน่วยลงทุนในระยะยาว โดยจะลงทุนในหน่วยลงทุนของกองทุนรวมต่างประเทศ ชื่อ JPMorgan Funds - Global Healthcare Fund, Class: JPM Global Healthcare C (acc) – USD (“กองทุนหลัก”) ซึ่งเป็นกองทุนรวมที่เสนอขายให้กับผู้ลงทุนทั่วไป… Its largest holdings are Eli Lilly 7.80% · AbbVie 6.90% · Johnson & Johnson 6.10% (fact sheet 30 Sep 2026)
Risk level 7 of 8 (High risk). Since 1 Feb 2018, its NAV has fallen as much as −24.91% from its peak.
Actual total expense ratio (TER) 1.53% a year, against a ceiling of 4.65%. Management fee 1.34%. Front-end fee 1.50%. Back-end fee 0.00%. (Fact sheet 30 Sep 2026)
No. Gains or losses accumulate in the NAV, and investors receive their return when they redeem units
Minimum first purchase 500 THB, subsequent purchases 500 THB. Buy orders accepted until 15:30, sell orders until 14:30, and redemption proceeds are paid T+4
Hedged at the manager's discretion. As of 30 Sep 2026, 0.00% of the value of its foreign investments was hedged
They are share classes of the same fund and invest in the same assets. They differ only in each class's terms, such as dividend policy, fees or who can buy · KFHEALTH-A: no dividends, TER 1.53% · KFHEALTH-D: pays dividends, TER 1.53%
Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
Merck & MRK5.25%
Thermo Fisher TMO4.56%
Novartis NOVN4.46%
AstraZeneca AZN.L4.06%
Unitedhealth Group UNH3.27%
Abbott Laboratories ABT2.87%
Danaher DHR2.87%Eli Lilly and Co LLYDiabetes and weight-loss drugs
ABBVIE ABBVHospitals, medicines and medical equipment
An American medicines and medical devices company, with products such as cancer drugs and surgical instruments
Merck & MRKHospitals, medicines and medical equipment
Thermo Fisher TMOAn American company selling scientific instruments, reagents and services for laboratories
Novartis NOVNHospitals, medicines and medical equipment
AstraZeneca AZN.LHospitals, medicines and medical equipment
Hospitals, medicines and medical equipment
Hospitals, medicines and medical equipment
Danaher DHRHospitals, medicines and medical equipment
Based on the master fund's share of this fund's value (99.06% as of 30 Sep 2026) × each stock's weight in the master fund · stocks as of 30 Sep 2026 · fact sheet from JPMorgan · Illustrations are for explanation only, not individual stock recommendations
No. 1 is SCBGENOME(E) +21.97% per year
No. 1 is FP HCARE-A +6.61% per year
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Full year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −0.1 | −0.6 | −0.7 | −1.1 | +2.3 | +8.1 | −0.2 | +2.4 | −1.1 | +8.7 | −0.1 | · | +18.6* |
| 2025 | +6.8 | +0.1 | −3.8 | −3.8 | −5.9 | +1.2 | +0.0 | +1.8 | +0.5 | +5.3 | +7.3 | −3.2 | +5.4 |
| 2024 | +5.7 | +4.1 | +3.3 | −1.7 | −0.1 | +2.8 | −0.9 | +0.3 | −9.1 | +0.2 | +0.3 | −7.6 | −3.7 |
| 2023 | −4.7 | +4.6 | −1.5 | +1.5 | −2.2 | +5.9 | −2.4 | +1.8 | −0.8 | −8.1 | +4.1 | +4.6 | +1.8 |
| 2022 | −10.0 | −1.1 | +9.9 | −4.2 | −2.4 | +1.4 | +8.3 | −3.4 | +0.5 | +4.4 | −5.1 | −2.8 | −6.1 |
